371 related articles for article (PubMed ID: 19090868)
1. Correlates affecting survival in chronic hemodialysis patients: the combined impact of albumin and high hemoglobin levels on improving outcomes, local and national results.
Capelli JP; Kushner H
Hemodial Int; 2008 Oct; 12(4):450-62. PubMed ID: 19090868
[TBL] [Abstract][Full Text] [Related]
2. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
Servilla KS; Singh AK; Hunt WC; Harford AM; Miskulin D; Meyer KB; Bedrick EJ; Rohrscheib MR; Tzamaloukas AH; Johnson HK; Zager PG
Am J Kidney Dis; 2009 Sep; 54(3):498-510. PubMed ID: 19628315
[TBL] [Abstract][Full Text] [Related]
3. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.
Regidor DL; Kopple JD; Kovesdy CP; Kilpatrick RD; McAllister CJ; Aronovitz J; Greenland S; Kalantar-Zadeh K
J Am Soc Nephrol; 2006 Apr; 17(4):1181-91. PubMed ID: 16565261
[TBL] [Abstract][Full Text] [Related]
4. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
[TBL] [Abstract][Full Text] [Related]
5. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
Lacson E; Ofsthun N; Lazarus JM
Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
[TBL] [Abstract][Full Text] [Related]
6. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients.
Kalantar-Zadeh K; Don BR; Rodriguez RA; Humphreys MH
Am J Kidney Dis; 2001 Mar; 37(3):564-72. PubMed ID: 11228181
[TBL] [Abstract][Full Text] [Related]
7. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
Lacson E; Wang W; Hakim RM; Teng M; Lazarus JM
Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570
[TBL] [Abstract][Full Text] [Related]
8. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
9. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study].
Peña JM; Logroño JM; Pernaute R; Laviades C; Virto R; Vicente de Vera C
Nefrologia; 2006; 26(1):84-97. PubMed ID: 16649429
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
[TBL] [Abstract][Full Text] [Related]
11. Anemia treatment in the pre-ESRD period and associated mortality in elderly patients.
Xue JL; St Peter WL; Ebben JP; Everson SE; Collins AJ
Am J Kidney Dis; 2002 Dec; 40(6):1153-61. PubMed ID: 12460033
[TBL] [Abstract][Full Text] [Related]
12. Association between hematocrit level and mortality in hemodialysis patients. Case study of the anemic patient.
Collins A; Ellefson J
Nephrol Nurs J; 2000 Apr; 27(2):233-6. PubMed ID: 11111551
[TBL] [Abstract][Full Text] [Related]
13. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.
Bradbury BD; Do TP; Winkelmayer WC; Critchlow CW; Brookhart MA
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):932-40. PubMed ID: 19572312
[TBL] [Abstract][Full Text] [Related]
14. Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis.
Anees M; Mumtaz A; Ibrahim M; Shaheen SM; Asghar A
Iran J Kidney Dis; 2010 Jan; 4(1):60-5. PubMed ID: 20081306
[TBL] [Abstract][Full Text] [Related]
15. Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs.
Lacson E; Ikizler TA; Lazarus JM; Teng M; Hakim RM
J Ren Nutr; 2007 Nov; 17(6):363-71. PubMed ID: 17971308
[TBL] [Abstract][Full Text] [Related]
16. [DOPPS estimate of patient life years attributable to modifiable hemodialysis practices in Spain].
Piera L; Cruz JM; Braga-Gresham JL; Eichleay MA; Pisoni RL; Port FK
Nefrologia; 2007; 27(4):496-504. PubMed ID: 17944588
[TBL] [Abstract][Full Text] [Related]
17. Renal amyloidosis is associated with increased mortality in hemodialysis patients.
Sengul S; Arat Z; Ozdemir FN
Artif Organs; 2004 Sep; 28(9):846-52. PubMed ID: 15320948
[TBL] [Abstract][Full Text] [Related]
18. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Bommer J; Locatelli F; Satayathum S; Keen ML; Goodkin DA; Saito A; Akiba T; Port FK; Young EW
Am J Kidney Dis; 2004 Oct; 44(4):661-71. PubMed ID: 15384017
[TBL] [Abstract][Full Text] [Related]
19. The "right" of passage: surviving the first year of dialysis.
Wingard RL; Chan KE; Lazarus JM; Hakim RM
Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S114-20. PubMed ID: 19995993
[TBL] [Abstract][Full Text] [Related]
20. Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes.
Levin A; Djurdjev O; Duncan J; Rosenbaum D; Werb R
Nephrol Dial Transplant; 2006 Feb; 21(2):370-7. PubMed ID: 16249203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]